Gerresheimer
Bernd Dr. Metzner is an accomplished finance professional with extensive experience in senior roles. Currently serving as Chief Financial Officer at Gerresheimer since May 2019, Metzner previously held the same title at Ströer SE & Co. KGaA from June 2014 to April 2019, and at DöhlerGroup from July 2011 to June 2014. Additionally, Metzner contributed to Bayer Schering Pharma from January 2002 to April 2011 in various capacities, including Head of Business Planning & Administration and Board Member, as well as Chief Financial Officer for Italy. Metzner's early career includes a role in tax consultancy at Flick Gocke Schaumburg and a trainee position in Bayer's Group Finance Program. Educational qualifications include a Diplom-Kaufmann from Universität Siegen, a Dr. rer. pol. from Universität Siegen, and advanced studies at The Wharton School and Harvard Business School, complemented by the Steuerberater certification.
This person is not in the org chart
This person is not in any teams
Gerresheimer
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.